Materialise: A High-Margin Medical Business Hiding In Plain Sight

Materialise's Medical continues to deliver double-digit growth and strong margins and is increasingly underpinning the company's value. The Manufacturing segment is recovering, with aerospace strength offsetting weak prototyping demand and creating significant potential for margin expansion. Software is now an uncertainty, as recurring revenue growth has stalled despite Materialise's transition toward subscriptions and the introduction of new CO-AM products.

Seeking Alpha • Aug 31, 2026

Materialise Q2 Earnings Call Highlights

Materialise NASDAQ: MTLS reported second-quarter revenue growth of more than 8% year over year to €70.1 million, driven by double-digit expansion in its Medical segment and continued improvement in profitability. The company raised its full-year adjusted EBIT outlook while maintaining its revenue guidance, despite the anticipated revenue effect of divesting its RapidFit and Eyewear businesses.

MarketBeat • Aug 27, 2026

Materialise NV (MTLS) Q2 2026 Earnings Call Transcript

Materialise NV (MTLS) Q2 2026 Earnings Call Transcript

Seeking Alpha • Aug 27, 2026

Materialise Reports Second Quarter and Half-Year 2026 Results

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its financial results for the second quarter and the six months ended June 30, 2026. Highlights – Second Quarter 2026 Total revenue increased by 8.1% to 70,073 kEUR for the second quarter of 2026 compared to 64,831 kEUR for the corresponding 2025 period. Adjusted EBITDA increased.

Business Wire • Aug 27, 2026

Materialise NV to Report Second Quarter and Half-Year 2026 Earnings on Thursday, August 27, 2026

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced that it will release financial results for the second quarter and the six months ended June 30, 2026 on Thursday, August 27, 2026 at 1:00 a.m. ET/7:00 a.m. CET. Senior management will hold a conference call to discuss the second quarter and the six months ended June 30, 2026 fina.

Business Wire • Aug 13, 2026

Materialise: Maturing Transition Should Lead To Stronger Performance Going Forward

While Materialise's Q1 results were soft, its Medical segment appears to be stabilizing and the software business model transition is nearing completion. Cost discipline and a return to growth should see margins start to consistently move higher, assuming that the macro environment remains stable. Despite the stock moving higher in recent months, a material improvement in performance still isn't priced into the stock.

Seeking Alpha • Jul 22, 2026

Annual General Meeting of Materialise NV held at the registered office of the Company on Tuesday 16 June 2026 at 10:00 (CET): Resolutions

LEUVEN, Belgium, July 01, 2026 (GLOBE NEWSWIRE) -- MATERIALISE NV Technologielaan 153001 LeuvenCompany number: 0441.131.254RPR Leuven

GlobeNewsWire • Jul 1, 2026

MATERIALISE NV RESULTS OF ANNUAL GENERAL SHAREHOLDERS' MEETING OF 16 JUNE 2026

LEUVEN, Belgium, June 17, 2026 (GLOBE NEWSWIRE) --   Regulated information [1]

GlobeNewsWire • Jun 17, 2026

All You Need to Know About Materialise (MTLS) Rating Upgrade to Buy

Materialise (MTLS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Investment Research • Jun 15, 2026

Best Stocks to Buy Before June 2026: 3 Breakout Stocks Ready to Surge

MTLS, LXFR and ARKO emerged as June breakout stock picks after strong gains and screening tied to price momentum and resistance levels.

Zacks Investment Research • May 29, 2026